A new coronavirus associated with human respiratory disease in China

Cited by (1,042)

Items 501–600 of 1,042

1. Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein
   Xiaoyi Fan, Duanfang Cao, Lingfei Kong, Xinzheng Zhang · 2020 · Nature Communications
2. Abnormal lung quantification in chest CT images of COVID‐19 patients with deep learning and its application to severity prediction
   Fei Shan, Yaozong Gao, Jun Wang, Weiya Shi, Nannan Shi, Miaofei Han, Zhong Xue, Dinggang G. Shen, Yuxin Shi · 2020 · Medical Physics
3. Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants
   Lingshu Wang, Tongqing Zhou, Yi Zhang, Eun Sung Yang, Chaim A. Schramm, Wei Shi, Amarendra Pegu, Olamide K. Oloniniyi, Amy R. Henry, Samuel W. Darko et al. · 2021 · Science
4. Overview of SARS-CoV-2 genome-encoded proteins
   Chongzhi Bai, Qiming Zhong, George F. Gao · 2021 · Science China Life Sciences
5. Advances in Circular RNA and Its Applications
   Xian Zhao, Youxiu Zhong, Xudong Wang, Jiuheng Shen, Wenlin An · 2022 · International Journal of Medical Sciences
6. A Novel Reverse Transcription Loop-Mediated Isothermal Amplification Method for Rapid Detection of SARS-CoV-2
   Renfei Lu, Xiuming Wu, Zhenzhou Wan, Yingxue Li, Xia Jin, Chiyu Zhang · 2020 · International Journal of Molecular Sciences
7. Spider‐Web‐Inspired PM 0.3 Filters Based on Self‐Sustained Electrostatic Nanostructured Networks
   Shichao Zhang, Hui Liu, Ning Tang, Sheng Zhou, Jianyong Yu, Bin Ding · 2020 · Advanced Materials
8. Structural Characterization of SARS-CoV-2: Where We Are, and Where We Need to Be
   Giuseppina Mariano, Rebecca J. Farthing, Shamar L. M. Lale-Farjat, Julien R. C. Bergeron · 2020 · Frontiers in Molecular Biosciences
9. The architecture of the SARS-CoV-2 RNA genome inside virion
   Changchang Cao, Zhaokui Cai, Xia Xiao, Jian Yu Rao, Juan Chen, Naijing Hu, Minnan Yang, Xiaorui Xing, Yongle Wang, Manman Li et al. · 2021 · Nature Communications
10. Rapid and sensitive detection of COVID-19 using CRISPR/Cas12a-based detection with naked eye readout, CRISPR/Cas12a-NER
    Xinjie Wang, Mingtian Zhong, Liu Y, Peixiang Ma, Lu Dang, Qingzhou Meng, Wenwei Wan, Xiaodong Ma, Jia Liu, Guang Yang et al. · 2020 · 中国科学通报：英文版
11. Epidemiological characteristics of COVID-19: a systematic review and meta-analysis
    Malahat Khalili, Mohammad Karamouzian, Naser Nasiri, Sara Javadi, Ali Mirzazadeh, Hamid Pour Sharifi · 2020 · Epidemiology and Infection
12. Computational evaluation of major components from plant essential oils as potent inhibitors of SARS-CoV-2 spike protein
    Seema A. Kulkarni, Santhosh Kumar Nagarajan, Veena Ramesh, Palaniyandi Velusamy, S. Periyar Selvam, Thirumurthy Madhavan · 2020 · Journal of Molecular Structure
13. Analysis of SARS-CoV-2 mutations in the United States suggests presence of four substrains and novel variants
    Rui Wang, Jiahui Chen, Kaifu Gao, Yuta Hozumi, Changchuan Yin, Guo‐Wei Wei · 2021 · Communications Biology
14. Evidence of recombination in coronaviruses implicating pangolin origins of nCoV-2019
    Matthew C. Wong, Sara Javornik Cregeen, Nadim J. Ajami, Joseph F. Petrosino · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
15. A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic
    Colin D. Funk, Craig A. Laferrière, Ali Ardakani · 2020 · Frontiers in Pharmacology
16. Contamination-free visual detection of SARS-CoV-2 with CRISPR/Cas12a: A promising method in the point-of-care detection
    Yanju Chen, Ya Shi, Yin Chen, Zhangnv Yang, Hui Wu, Zhihui Zhou, Jue Li, Jianfeng F Ping, Lu-Ping He, Hong Shen et al. · 2020 · Biosensors and Bioelectronics
17. Mutations on COVID-19 diagnostic targets
    Rui Wang, Y. Hozumi, Changchuan Yin, G. Wei · 2020 · Genomics
18. Natural selection in the evolution of SARS-CoV-2 in bats created a generalist virus and highly capable human pathogen
    Oscar A. MacLean, Spyros Lytras, Steven Weaver, Joshua B. Singer, Maciej F. Boni, Philippe Lemey, Sergei L. Kosakovsky Pond, David L. Robertson · 2021 · PLoS Biology
19. Human ACE2-Functionalized Gold “Virus-Trap” Nanostructures for Accurate Capture of SARS-CoV-2 and Single-Virus SERS Detection
    Yong Ping Yang, Yusi Peng, Chenglong Lin, Long Li, Jingying Hu, Jun He, Hui Zeng, Zhengren Huang, Zhiyuan Li, Masaki Tanemura et al. · 2021 · Nano-Micro Letters
20. ORF3a of SARS-CoV-2 promotes lysosomal exocytosis-mediated viral egress
    Di Chen, Qiaoxia Zheng, Long Sun, Ming-Ming Ji, Yan Li, Hongyu Deng, Hong Zhang · 2021 · Developmental Cell
21. Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission
    Sayantan Laha, Joyeeta Chakraborty, Shantanab Das, Soumen Kanti Manna, Sampa Biswas, Raghunath Chatterjee · 2020 · Infection Genetics and Evolution
22. A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants
    Bethany L. Dearlove, Éric Lewitus, Hongjun Bai, Yifan Li, Daniel B. Reeves, Michael Gordon Joyce, Paul T. Scott, Mihret F. Amare, Sandhya Vasan, Nelson L. Michael et al. · 2020 · Proceedings of the National Academy of Sciences
23. RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response
    Zezhong Liu, Wei Xu, Shuai Xia, Chenjian Gu, Xinling Wang, Qian Wang, Jie Zhou, Yanling Wu, Xia Cai, Di Qu et al. · 2020 · Signal Transduction and Targeted Therapy
24. Isolation and Characterization of 2019-nCoV-like Coronavirus from Malayan Pangolins
    Kangpeng Xiao, Junqiong Zhai, Yaoyu Feng, Niu Zhou, Xu Zhang, Jiejian Zou, Na Li, Yaqiong Guo, Xiaobing Li, Xuejuan Shen et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
25. 2019-Novel Coronavirus (2019-nCoV): estimating the case fatality rate – a word of caution
    Manuel Battegay, Richard Küehl, Sarah Tschudin‐Sutter, Hans Hellmuth Hirsch, Andreas Franz Widmer, Richard A. Neher · 2020 · Swiss Medical Weekly
26. A Preliminary Evaluation of the Public Risk Perception Related to the COVID-19 Health Emergency in Italy
    Giulia Motta Zanin, Eleonora Gentile, Alessandro Parisi, Danilo Spasiano · 2020 · International Journal of Environmental Research and Public Health
27. Sport and exercise in times of self-quarantine: How Germans changed their behaviour at the beginning of the Covid-19 pandemic
    Michael Mutz, Markus Gerke · 2020 · International Review for the Sociology of Sport
28. Serum Proteomics in COVID-19 Patients: Altered Coagulation and Complement Status as a Function of IL‑6 Level
    Angelo D’Alessandro, Tiffany A. Thomas, Monika Dzieciątkowska, Ryan C. Hill, Richard O. Francis, Krystalyn E. Hudson, James C. Zimring, Eldad A. Hod, Steven L. Spitalnik, Kirk Charles Hansen · 2020 · Journal of Proteome Research
29. Identification of Potent COVID-19 Main Protease (Mpro) Inhibitors from Natural Polyphenols: An in Silico Strategy Unveils a Hope against CORONA
    Şevki Adem, Volkan Eyüpoğlu, Iqra Sarfraz, Azhar Rasul, Muhammad Ali · 2020 · Preprints.org
30. Biological and social aspects of Coronavirus Disease 2019 (COVID-19) related to oral health
    Luciano José Pereira, Cássio Vicente Pereira, Ramiro Mendonça Murata, Vanessa Pardi, Stela Márcia Pereira · 2020 · Brazilian Oral Research
31. Myelin Oligodendrocyte Glycoprotein Antibody–Associated Optic Neuritis and Myelitis in COVID-19
    Siwei Zhou, Edward C. Jones‐López, Deepak J. Soneji, Christina J. Azevedo, Vivek Ravindra Patel · 2020 · Journal of Neuro-Ophthalmology
32. Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection
    Raveen Rathnasinghe, Shirin Strohmeier, Fatima Amanat, Virginia Gillespie, Florian Krammer, Adolfo García‐Sastre, Lynda Coughlan, Michael Schotsaert, Melissa B. Uccellini · 2020 · Emerging Microbes & Infections
33. Theoretical basis for stabilizing messenger RNA through secondary structure design
    Wayment-Steele, Hannah K, Kim, Do Soon, Choe, Christian A, Nicol, John J, Wellington-Oguri, Roger, Watkins, Andrew M, Parra Sperberg, R Andres, Huang, Po-Ssu, Participants, Eterna, Das, Rhiju · 2021 · Nucleic Acids Research
34. The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status
    Mbarka Bchetnia, Catherine Girard, Caroline Duchaine, Catherine Laprise · 2020 · Journal of Infection and Public Health
35. A Recurrent Mutation at Position 26340 of SARS-CoV-2 Is Associated with Failure of the E Gene Quantitative Reverse Transcription-PCR Utilized in a Commercial Dual-Target Diagnostic Assay
    Maria Artesi, Sébastien Bontems, Paul Göbbels, Marc Franckh, Piet Maes, Raphaël Boreux, Cécile Meex, Pierrette Melin, Marie‐Pierre Hayette, Vincent Bours et al. · 2020 · Journal of Clinical Microbiology
36. Emerging New Concepts of Degrader Technologies
    Ding, Yu, Fei, Yiyan, Lu, Boxun · 2020 · Trends in Pharmacological Sciences
37. N- and O-Glycosylation of the SARS-CoV-2 Spike Protein
    Miloslav Šanda, Lindsay J. Morrison, Radoslav Goldman · 2021 · Analytical Chemistry
38. Transcriptional and proteomic insights into the host response in fatal COVID-19 cases
    Meng–Huang Wu, Yaobing Chen, Han Xia, Changli Wang, Chin Yee Tan, Xunhui Cai, Yufeng Liu, Fenghu Ji, Xiong Peng, Ran Liu et al. · 2020 · Proceedings of the National Academy of Sciences
39. Evolution patterns of SARS-CoV-2: Snapshot on its genome variants
    Marta Giovanetti, Francesca Benedetti, Giovanni Campisi, Alessandra Ciccozzi, Silvia Fabris, Giancarlo Ceccarelli, Vittoradolfo Tambone, Arnaldo Caruso, Silvia Angeletti, Davide Zella et al. · 2020 · Biochemical and Biophysical Research Communications
40. Adsorption of environmental contaminants on micro- and nano-scale plastic polymers and the influence of weathering processes on their adsorptive attributes
    Prabhat Kumar Rai, Christian Sonne, Richard J. C. Brown, Sherif A. Younis, Ki‐Hyun Kim · 2021 · Journal of Hazardous Materials
41. Wastewater surveillance of pathogens can inform public health responses
    Megan B. Diamond, Aparna P. Keshaviah, Ana I. Bento et al. · 2022 · Nature Medicine
42. COVID-19 revisiting inflammatory pathways of arthritis
    Schett, Georg, Manger, Bernhard, Simon, David, Caporali, Roberto · 2020 · Nature Reviews Rheumatology
43. Definition and Risks of Cytokine Release Syndrome in 11 Critically Ill COVID-19 Patients With Pneumonia: Analysis of Disease Characteristics
    Wenjun Wang, Xiaoqing Liu, Si-Pei Wu, Sibei Chen, Yimin Li, Lingbo Nong, Puyi Lie, Liyan Huang, Linling Cheng, Yongping Lin et al. · 2020 · The Journal of Infectious Diseases
44. Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatics approach
    Abdus Samad, Foysal Ahammad, Zulkar Nain, Rahat Alam, Raihan Rahman Imon, Mahadi Hasan, Md. Shahedur Rahman · 2020 · Journal of Biomolecular Structure and Dynamics
45. Depression, stress, anxiety and their predictors in Iranian pregnant women during the outbreak of COVID-19
    Fatemeh Effati-Daryani, Somayeh Zarei, Azam Mohammadi, Elnaz Hemmati, Sakineh Ghasemi Yngyknd, Mojgan Mirghafourvand‬‬‬‬‬‬‬‬‬‬‬‬‬‬ · 2020 · BMC Psychology
46. One year update on the COVID-19 pandemic: Where are we now?
    Sanjay Kumar Mishra, Timir Tripathi · 2020 · Acta Tropica
47. Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity
    Kathryn A. Ryan, Kevin R. Bewley, Susan A. Fotheringham, Gillian S. Slack, Phillip J. Brown, Yper Hall, Nadina I. Vasileva Wand, Anthony C. Marriott, Breeze E. Cavell, Julia A. Tree et al. · 2021 · Nature Communications
48. Deep learning for COVID-19 detection based on CT images
    Wentao Zhao, Wei Jiang, Xinguo Qiu · 2021 · Scientific Reports
49. The pulmonary pathology of COVID-19
    Bösmüller, Hans, Matter, Matthias, Fend, Falko, Tzankov, Alexandar · 2021 · Virchows Archiv
50. A novel rapid detection for SARS-CoV-2 spike 1 antigens using human angiotensin converting enzyme 2 (ACE2)
    Jong-Hwan Lee, Minsuk Choi, Yujin Jung, Sung Kyun Lee, Chang‐Seop Lee, Jung Kim, Jong-Woo Kim, Nam Hoon Kim, Bum‐Tae Kim, Hong Gi Kim · 2020 · Biosensors and Bioelectronics
51. SARS‐CoV‐2, the pandemic coronavirus: Molecular and structural insights
    Swapnil B. Kadam, Geetika S. Sukhramani, Pratibha Bishnoi, Anupama A. Pable, Vitthal Tanaji Barvkar · 2021 · Journal of Basic Microbiology
52. Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning
    Onat Kadioglu, Mohamed E.M. Saeed, Henry Johannes Greten, Thomas Efferth · 2021 · Computers in Biology and Medicine
53. Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?
    Ivana Lazarević, Vera Pravica, Danijela Miljanovic, Maja D. Cupic · 2021 · Viruses
54. The Pathogenesis of Coronavirus Disease 2019 (COVID‐19): Evaluation and Prevention
    Hayat Ouassou, Loubna Kharchoufa, Mohamed Bouhrim, Nour Elhouda Daoudi, Hamada Imtara, Noureddine Bencheikh, Amine Elbouzidi, Mohamed Bnouham · 2020 · Journal of Immunology Research
55. COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies
    Renuka Raman, Krishna J. Patel, Kishu Ranjan · 2021 · Biomolecules
56. Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2
    Jiahua He, Huanyu Tao, Yumeng Yan, Sheng‐You Huang, Yi Xiao · 2020 · Viruses
57. Prognosis of COVID-19 in Patients with Liver and Kidney Diseases: An Early Systematic Review and Meta-Analysis
    Tope Oyelade, Jaber Saud Alqahtani, Gabriele Canciani · 2020 · Tropical Medicine and Infectious Disease
58. Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients
    Larry L. Luchsinger, Brett P. Ransegnola, Daniel K. Jin, Frauke Muecksch, Yiska Weisblum, Weili Bao, Parakkal Jovvian George, Marilis Rodriguez, Nancy Tricoche, Fabian Schmidt et al. · 2020 · Journal of Clinical Microbiology
59. Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection
    Bo Diao, Kun Wen, Ji Zhang, Jian Chen, Chao Qun Han, Yongwen Chen, Shufeng Wang, Guohong Deng, Hongwei Zhou, Yuzhang Wu · 2020 · Clinical Microbiology and Infection
60. Blood molecular markers associated with COVID‐19 immunopathology and multi‐organ damage
    Yanmei Chen, Yuanting Zheng, Ying Yu, Yunzhi Wang, Qingxia Huang, Feng Qian, Lei Sun, Zhigang Song, Ziyin Chen, Jinwen Feng et al. · 2020 · The EMBO Journal
61. Antivirals for COVID-19: A critical review
    Andri Frediansyah, Ruchi Tiwari, Khan Sharun, Kuldeep Dhama, Harapan Harapan · 2020 · Clinical Epidemiology and Global Health
62. Effects of SARS-CoV-2 variants on vaccine efficacy and response strategies
    Lianlian Bian, Fan Gao, Jialu Zhang, Qian He, Qunying Mao, Miao Xu, Zhenglun Liang · 2021 · Expert Review of Vaccines
63. RNA-Dependent RNA Polymerase as a Target for COVID-19 Drug Discovery
    Wei Jian Zhu, Catherine Z. Chen, Kirill Gorshkov, Miao Xu, Donald C. Lo, Wei Zheng · 2020 · SLAS DISCOVERY
64. Comparative Analysis of Primer–Probe Sets for RT-qPCR of COVID-19 Causative Virus (SARS-CoV-2)
    Yujin Jung, Gun-Soo Park, Jun Hye Moon, Keun Bon Ku, Seung-Hwa Beak, Chang‐Seop Lee, Seil Kim, Edmond Changkyun Park, Daeui Park, Jong-Hwan Lee et al. · 2020 · ACS Infectious Diseases
65. SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes
    Irwin Jungreis, Rachel S. G. Sealfon, M Kellis · 2021 · Nature Communications
66. COVID-19 Detection from Chest X-ray Images Using Feature Fusion and Deep Learning
    Nur-A-Alam Alam, Mominul Ahsan, Md. Abdul Based, Julfikar Haider, Marcin Kowalski · 2021 · Sensors
67. An In Vitro Microneutralization Assay for SARS‐CoV‐2 Serology and Drug Screening
    Fatima Amanat, Kris M. White, Lisa Miorin, Shirin Strohmeier, Meagan McMahon, Philip S. Meade, Wen‐Chun Liu, Randy A. Albrecht, Viviana R. Simon, Luis Martínez‐Sobrido et al. · 2020 · Current Protocols in Microbiology
68. The Therapeutic Potential of Mesenchymal Stromal Cells for Regenerative Medicine: Current Knowledge and Future Understandings
    Makram Merimi, Rania El Majzoub, Laurence Lagneaux, Douâa Moussa Agha, Fatima Bouhtit, Nathalie Meuleman, Hassan Fahmi, Philippe Lewalle, Mohammad Fayyad‐Kazan, Mehdi Najar · 2021 · Frontiers in Cell and Developmental Biology
69. Liquid–liquid phase separation by SARS-CoV-2 nucleocapsid protein and RNA
    Hui Chen, Yang Cui, Xuling Han, Wei Hu, Min Sun, Yong Zhang, Pei‐Hui Wang, Guangtao Song, Wei Chen, Jizhong Lou · 2020 · Cell Research
70. Hearing Loss, Tinnitus, and Dizziness in COVID-19: A Systematic Review and Meta-Analysis
    Zahra Jafari, Bryan E Kolb, Majid H. Mohajerani · 2021 · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
71. Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis
    Yifan Meng, Wanrong Lu, Ensong Guo, Jia Liu, Bin Yang, Ping Wu, Shitong Lin, Ting Peng, Yu Fu, Fuxia Li et al. · 2020 · Journal of Hematology & Oncology
72. Characterization of accessory genes in coronavirus genomes
    Christian J. Michel, Claudine Mayer, Olivier Poch · 2020 · Virology Journal
73. Lung Histopathology in Coronavirus Disease 2019 as Compared With Severe Acute Respiratory Sydrome and H1N1 Influenza
    Lida P. Hariri, Crystal M. North, Angela R. Shih, Rebecca A. Israel, Jason H. Maley, Julian A. Villalba, Vladimir Vinarsky, Jonah N. Rubin, Daniel A. Okin, Alyssa Sclafani et al. · 2020 · CHEST Journal
74. Establishment of a reverse genetics system for SARS-CoV-2 using circular polymerase extension reaction
    Shiho Torii, Chikako Ono, Rigel Suzuki, Yuhei Morioka, Itsuki Anzai, Yuzy Fauzyah, Yusuke Maeda, Wataru Kamitani, Takasuke Fukuhara, Yoshiharu Matsuura · 2021 · Cell Reports
75. The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance
    Houriiyah Tegally, James Emmanuel San, Matthew L. Cotten, Monika Moir, Bryan Tegomoh, Gerald Mboowa, Darren Patrick Martin, Cheryl Baxter, Arnold W. Lambisia, Amadou Bailo Diallo et al. · 2022 · Science
76. ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaques
    van Doremalen, Neeltje, Lambe, Teresa, Spencer, Alexandra, Belij-Rammerstorfer, Sandra, Purushotham, Jyothi N., Port, Julia R., Avanzato, Victoria, Bushmaker, Trenton, Flaxman, Amy, Ulaszewska, Marta et al. · 2020
77. Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients
    Yang Li, Dan‐yun Lai, Hainan Zhang, He‐wei Jiang, Xiaolong Tian, Ming‐liang Ma, Huan Qi, Qingfeng Meng, Shujuan Guo, Yanling Wu et al. · 2020 · Cellular and Molecular Immunology
78. Potential Factors Influencing Repeated SARS Outbreaks in China
    Zhong Sun, Karuppiah Thilakavathy, Suresh S. Kumar, Guozhong He, Shi V. Liu · 2020 · International Journal of Environmental Research and Public Health
79. ACEI/ARB use and risk of infection or severity or mortality of COVID-19: A systematic review and meta-analysis
    Xue Zhang, Jiong Yu, Li‐ya Pan, Hai-yin Jiang · 2020 · Pharmacological Research
80. Bioactive natural compounds against human coronaviruses: a review and perspective
    Yan‐Fang Xian, Juan Zhang, Zhaoxiang Bian, Hua Zhou, Zhenbiao Zhang, Zhixiu Lin, Hong‐Xi Xu · 2020 · Acta Pharmaceutica Sinica B
81. Expression of Concern: Th17 and Treg cells function in SARS‐CoV2 patients compared with healthy controls
    Armin Sadeghi, Safa Tahmasebi, Arshad Mahmood, Maria S. Kuznetsova, Hamed Valizadeh, Ali Taghizadieh, Masoud Nazemiyeh, Leili Aghebati Maleki, Farhad Jadidi‐Niaragh, Sanaz Abbaspour‐Aghdam et al. · 2020 · Journal of Cellular Physiology
82. Consensus for prevention and management of coronavirus disease 2019 (COVID-19) for neurologists
    Huijuan Jin, Candong Hong, Shengcai Chen, Yifan Zhou, Yong Wang, Ling Mao, Yanan Li, Quanwei He, Man Li, Ying Su et al. · 2020 · Stroke and Vascular Neurology
83. Clinical, immunological and virological characterization of COVID-19 patients that test re-positive for SARS-CoV-2 by RT-PCR
    Jing Lu, Jin-Ju Peng, Qian-Ling Xiong, Zhe Liu, Hui-Fang Lin, Xiao-Hua Tan, Min Kang, Run-Yu Yuan, Lilian Zeng, Pingping Zhou et al. · 2020 · medRxiv
84. An overview of current COVID-19 vaccine platforms
    Abdou Nagy, B. Alhatlani · 2021 · Computational and Structural Biotechnology Journal
85. Structure-based de novo drug design using 3D deep generative models
    Yibo Li, Jianfeng Pei, Luhua Lai · 2021 · Chemical Science
86. SARS-CoV-2 spike S1 subunit induces neuroinflammatory, microglial and behavioral sickness responses: Evidence of PAMP-like properties
    Matthew G. Frank, Kathy Nguyen, Jayson B. Ball, Shelby Hopkins, Tel Kelley, Michael V. Baratta, Monika Fleshner, Steven F. Maier · 2021 · Brain Behavior and Immunity
87. Exploring the Natural Origins of SARS-CoV-2 in the Light of Recombination
    Spyros Lytras, Joseph Hughes, Darren Patrick Martin, Phillip Swanepoel, Arné de Klerk, Rentia Lourens, Sergei L. Kosakovsky Pond, Wei Xia, Xiaowei Jiang, David L. Robertson · 2022 · Genome Biology and Evolution
88. SARS-CoV-2 mRNA vaccines induce broad CD4+ T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63
    Woldemeskel, Bezawit A., Garliss, Caroline C., Blankson, Joel N. · 2021 · Journal of Clinical Investigation
89. Natural Killer Cell Dysfunction and Its Role in COVID-19
    Charmaine van Eeden, Lamia Khan, Mohammed S. Osman, Jan Willem Cohen Tervaert · 2020 · International Journal of Molecular Sciences
90. Genetics and genomics of SARS-CoV-2: A review of the literature with the special focus on genetic diversity and SARS-CoV-2 genome detection
    Azadeh Rahimi, Azin Mirzazadeh, Soheil Tavakolpour · 2020 · Genomics
91. Prolonged Persistence of SARS-CoV-2 RNA in Body Fluids
    Jiufeng Sun, Jianpeng Xiao, Ruilin Sun, Xi Tang, Chumin Liang, Huifang Lin, Lilian Zeng, Jianxiong Hu, Runyu Yuan, Pingping Zhou et al. · 2020 · Emerging infectious diseases
92. Human SARS CoV ‐2 spike protein mutations
    Lalitha Guruprasad · 2021 · Proteins Structure Function and Bioinformatics
93. Timing the SARS-CoV-2 index case in Hubei Province
    Pekar, Jonathan, Worobey, Michael, Moshiri, Niema, Scheffler, Konrad, Wertheim, Joel O. · 2021 · Science
94. Fighting against the common enemy of COVID-19: a practice of building a community with a shared future for mankind
    Xu Qian, Ran Ren, Youfa Wang, Yan Ping Guo, Jing Fang, Zhongdao Wu, Peilong Liu, Tie-Ru Han · 2020 · Infectious Diseases of Poverty
95. Features of Mild-to-Moderate COVID-19 Patients With Dysphonia
    Jerome Rene Lechien, Carlos Miguel Chiesa-Estomba, Pierre Cabaraux, Quentin Mat, Kathy Huet, Bernard Georges Harmegnies, Mihaéla Horoi, Serge Daniel Le Bon, Alexandra Rodriguez, Didier Dequanter et al. · 2020 · Journal of Voice
96. In silico investigation of phytoconstituents from Indian medicinal herb ‘Tinospora cordifolia(giloy)’ against SARS-CoV-2 (COVID-19) by molecular dynamics approach
    Papia Chowdhury · 2020 · Journal of Biomolecular Structure and Dynamics
97. High levels of eicosanoids and docosanoids in the lungs of intubated COVID‐19 patients
    Anne‐Sophie Archambault, Younes Zaid, Volatiana Rakotoarivelo, Caroline Turcotte, Étienne Doré, Isabelle Dubuc, Cyril Martin, Olivier Flamand, Youssef Amar, Amine Cheikh et al. · 2021 · The FASEB Journal
98. SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8 ⁺ T cell responses
    Agerer, Benedikt, Koblischke, Maximilian, Gudipati, Venugopal, Montaño-Gutierrez, Luis Fernando, Smyth, Mark, Popa, Alexandra, Genger, Jakob-Wendelin, Endler, Lukas, Florian, David M., Mühlgrabner, Vanessa et al. · 2021 · Science Immunology
99. COVID-19 y diabetes mellitus: una relación bidireccional
    Marcos M. Lima-Martínez, Carlos Carrera Boada, Marialaura D. Madera-Silva, Waleskha Marín, Miguel Contreras · 2020 · Clínica e Investigación en Arteriosclerosis
100. Gut microbiome alterations and gut barrier dysfunction are associated with host immune homeostasis in COVID-19 patients
     Zhonghan Sun, Zhigang Song, Chenglin Liu, Shishang Tan, Shuchun Lin, Jiajun Zhu, Fahui Dai, Jian Gao, Jia-Lei She, Zhendong Mei et al. · 2022 · BMC Medicine